Health TrialsbyHealthPanel

Primary Immunoglobulin a Nephropathy (IgAN)

1

Review clinical trials related to Primary Immunoglobulin a Nephropathy (IgAN). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

The study is an open-label, single arm, multicenter, Phase III study to determine proteinuria reduction, pharmacokinetics (PK), safety and tolerability (including CV surveillance) of iptacopan in primary immunoglobulin A nephropathy (IgAN) pediatric patients aged 2 to \<18 years.

Participants needed: 31
Trial details
Phase: Phase 3Age: 2-18Biological sex: AllType: InterventionalSponsor: Novartis PharmaceuticalsUpdated: Sep 9, 2026Locations: 20
Eligibility criteria

Male and female participants 2 to < 18 years of age as of Day 1. [+7]

Any secondary IgAN observed at Screening (and confirmed at Baseline/Day 1) as de... [+13]

Read more